Tilray Brands (NASDAQ:TLRY) Stock Price Down 2.1% – Here’s What Happened

Tilray Brands, Inc. (NASDAQ:TLRY)’s stock price was down 2.1% on Friday . The company traded as low as $7.45 and last traded at $7.46. Approximately 2,775,025 shares were traded during mid-day trading, a decline of 51% from the average daily volume of 5,641,340 shares. The stock had previously closed at $7.62.

Key Tilray Brands News

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Zacks argues TLRY has an edge over peers thanks to rising international revenue, scaled beverage operations and a stronger cash position — factors investors view as supportive of longer‑term upside as legalization and demand evolve. TLRY vs. CGC: Which Cannabis Stock is the Better Investment Now?
• Positive Sentiment: Tilray’s Terrapin Beer Co. unveiled a comprehensive brand refresh aimed at boosting consumer engagement for its craft-beer portfolio — a modest but tangible revenue/brand-strengthening move in the consumer segment. Terrapin Beer Co. Turns Up the Volume with a New Brand Identity
• Neutral Sentiment: Yahoo Finance takes a valuation-focused view, asking whether recent share-price weakness creates a buying opportunity — the piece highlights lower valuation but stresses that execution and margin recovery remain uncertain. Is Tilray Brands (TLRY) Offering Opportunity After Prolonged Share Price Declines
• Neutral Sentiment: Coverage on Tilray Medical Italia notes the company is testing its European medical-cannabis growth thesis in Italy — a potential growth avenue but one that depends on regulatory, distribution and reimbursement execution. Tilray Medical Italia Puts European Cannabis Growth Story To The Test
• Negative Sentiment: The company’s recent quarterly results included a material EPS miss and very weak margins (negative net margin and ROE), which remain the primary near‑term headwind and likely explain downward pressure on the share price. Tilray Brands Trading Down (MarketBeat summary)

Analysts Set New Price Targets

Several research analysts recently commented on TLRY shares. Roth Mkm cut their price target on Tilray Brands from $20.00 to $10.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 20th. Canaccord Genuity Group initiated coverage on Tilray Brands in a report on Tuesday, January 27th. They set a “hold” rating on the stock. Wall Street Zen upgraded Tilray Brands from a “strong sell” rating to a “hold” rating in a research note on Saturday, October 11th. Weiss Ratings reissued a “sell (d-)” rating on shares of Tilray Brands in a research report on Wednesday, January 21st. Finally, Atb Cap Markets raised shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 10th. One investment analyst has rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce” and an average price target of $13.33.

Tilray Brands Price Performance

The company has a quick ratio of 1.72, a current ratio of 2.81 and a debt-to-equity ratio of 0.19. The company has a 50 day simple moving average of $9.33 and a 200-day simple moving average of $10.96. The stock has a market cap of $869.16 million, a price-to-earnings ratio of -0.34 and a beta of 1.77.

Tilray Brands (NASDAQ:TLRY) last issued its quarterly earnings results on Thursday, January 8th. The company reported ($0.41) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.27). The firm had revenue of $217.51 million during the quarter, compared to the consensus estimate of $211.15 million. Tilray Brands had a negative net margin of 251.69% and a negative return on equity of 6.35%. During the same quarter last year, the firm posted ($0.03) earnings per share. As a group, research analysts anticipate that Tilray Brands, Inc. will post -0.2 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of TLRY. AQR Capital Management LLC grew its position in shares of Tilray Brands by 1,839.7% during the 1st quarter. AQR Capital Management LLC now owns 607,054 shares of the company’s stock valued at $399,000 after buying an additional 575,757 shares during the last quarter. Vontobel Holding Ltd. boosted its stake in Tilray Brands by 12.7% in the second quarter. Vontobel Holding Ltd. now owns 272,662 shares of the company’s stock valued at $113,000 after acquiring an additional 30,818 shares during the period. Blair William & Co. IL grew its holdings in shares of Tilray Brands by 55.9% during the second quarter. Blair William & Co. IL now owns 239,743 shares of the company’s stock valued at $99,000 after purchasing an additional 86,010 shares during the last quarter. Stratos Wealth Partners LTD. grew its holdings in shares of Tilray Brands by 704.5% during the second quarter. Stratos Wealth Partners LTD. now owns 81,272 shares of the company’s stock valued at $34,000 after purchasing an additional 71,170 shares during the last quarter. Finally, Tradewinds Capital Management LLC raised its position in shares of Tilray Brands by 177.0% during the 2nd quarter. Tradewinds Capital Management LLC now owns 203,461 shares of the company’s stock worth $84,000 after purchasing an additional 130,001 shares during the period. 9.35% of the stock is currently owned by institutional investors.

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.